Seeking Alpha

Cancer Genetics falls after secondary

  • Cancer Genetics (CGIX.OB -14.4%) plummets after pricing a 1.5M share public offering at $10, a 10% discount to Tuesday's close. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|